✦ LIBER ✦

Docetaxel (DTX) + cisplatin (CDDP) in locally advanced or metastatic head and neck cancer (HN). A phase II study

✍ Scribed by F. Caponigro; L. De Lucia; M. Biglietto; A. Avallone; F. Rivellini; C. Sguotti; L. Manzione; P. Comella; G. Mantovani; G. Comella

Book ID: 117667605
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 166 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(99)81061-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose cisplatin for locally advanced

High-dose cisplatin for locally advanced or metastatic head and neck cancer. A phase ii pilot study

✍ Kathleen A. Havlin; John G. Kuhn; J. William Myers; Robert F. Ozols; Douglas E. 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB 👁 2 views

Phase II Study of Weekly Docetaxel and C

Phase II Study of Weekly Docetaxel and Cisplatin in Patients With Advanced Recurrent and Metastatic Head and Neck Cancer

✍ Orlando Guntinas-Lichius; Stefan Appenrodt; Florian Veelken; Barbara Krug 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

‘Tomudex’ (raltitrexed) and cisplatin in

‘Tomudex’ (raltitrexed) and cisplatin in the treatment of patients with locally advanced or metastatic head and neck cancer (HNSCC): a Phase I/II study

✍ D. ten Bokkel Huinink; R.J. Batenburg de Jong; H.P. Verschuur; H.J. Keizer 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Phase II study of esorubicin (4′ -deoxyd

Phase II study of esorubicin (4′ -deoxydoxorubicin) in locally advanced or metastatic head and neck carcinoma

✍ Sergio Frustaci; Giampietro Gasparini; Andrea Veronesi; Umberto Tirelli; Maria A 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 232 KB

Sixteen patients with locally advanced or metastatic head and neck cancer were treated with esorubicin (4'-deoxydoxorubicin) at a dose of 30-35 mg/m 2 i.v. every 3 weeks. One patient was lost to the follow up after one cycle, whereas in the 15 evaluable cases a total of 34 courses were administered

A phase II randomized study of cisplatin

A phase II randomized study of cisplatin (CDDP), raltitrexed (TOM), levofolinic acid (LFA), and 5-fluorouracil (5-FU), or CDDP, methotrexate (MTX), LFA and 5-FU in locally advanced (LAD) or metastatic (M) head and neck cancer (HNC)

✍ F. Caponigro; P. De Rosa; G. Rosati; A. Avallone; L. De Lucia; B. Morrica; F. Io 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 364 KB

A phase II study of docetaxel and carbop

A phase II study of docetaxel and carboplatin with concurrent radiation therapy for locally advanced head and neck cancer

✍ Imjai Chitapanarux; Vicharn Lorvidhaya; Ekasit Tharavichitkul; Somvilai Mayurasa 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 138 KB